Vyne Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.64

+0.00 (+0.71%)

As of May 9, 2:20 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +2,939.6% upside

Low Target $14.75

Average Target $19.49

High Target $26.42

Current Price $0.64

Current
$0.64

Target
$19.49

$14.75 $19.49 avg $26.42

Scenario Analysis

Bear Case

$14.75

2,200.4%

Low target

Base Case

$19.49

+2,939.6%

Avg target

Bull Case

$26.42

+4,020.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$1.96

-67.3% from high

52-Week Low

$0.28

+128.6% from low

Target vs 52W High

$19.49

+894.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%